| Literature DB >> 35707335 |
Dong Wang1, Zhang Zhang1, Rui Dong1, Jianguo Lu1, Jikai Yin1.
Abstract
Introduction: Laparoscopic splenectomy and esophagogastric devascularization (LSED) is becoming increasingly popular in the treatment of esophageal-fundic variceal bleeding with portal hypertension (PHT) in China, and its high safety and minimal trauma have been proven. Fast-track (FT) surgery improves patient recovery and decreases postoperative complications. Aim: To determine whether LSED with fast-track principles can provide better outcomes than traditional treatment for patients with PHT. Material and methods: A total of 140 patients who underwent LSED with either traditional treatment or fast-track principles in our department were retrospectively analyzed. The postoperative outcomes, complications, inflammatory mediators, portal vein thrombosis (PVT) and recurrent esophagogastric variceal bleeding rate were recorded.Entities:
Keywords: devascularization; fast-track surgery; laparoscopic splenectomy; portal hypertension
Year: 2022 PMID: 35707335 PMCID: PMC9186085 DOI: 10.5114/wiitm.2021.112680
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.627
Photo 1Locations of trocars and key steps in laparoscopic splenectomy and esophagogastric devascularization. A – Trocar locations. (a) Laparoscopic observation incision (below or to the right of the navel). (b, c) Main operative incisions. (d, e) Assistant operative incisions. B – Separation and ligation of the splenic artery. C – Transection of splenic hilar pedicles with the Endo GIA stapler. D – Transection of the left gastric vein at the root with the Endo GIA stapler. E – Esophagogastric devascularization. F – Completion of totally laparoscopic surgery
Peri-operative management compared between the two groups
| FT group | Non-FT group | |
|---|---|---|
| Pre-operative | Detailed preoperative consultation and education | Similar education without fast-track surgery principles |
| Solid food and liquid fasting for 6 and 2 h, respectively Oral carbohydrates were administered in the early morning of the operative day | Fast from the night before operation | |
| No preoperative use of nasogastric tube | Routine use of nasogastric tube | |
| No intestinal preparation | Routine intestinal preparation | |
| Intra-operative | Anesthesia: limit infusions; shorten anesthesia time; avoid hypothermic conditions | Anesthesia: traditional way without special requirements |
| use nasogastric tube after anesthesia | ||
| Surgical operation: operative time control | Conventional operation | |
| Routine surgical drainage tubes | Routine surgical drainage tubes | |
| Post-operative | Early mobilization: in-bed activities the day after the operation, out of bed activities on the 1st postoperative day, then gradually increasing exercise to resume normal ambulation | Early mobilization: no |
| Enteral nutrition: drink small amounts of water after recovery from anesthesia; take liquid diet on the 1st postoperative day, then gradually introduce a semi-liquid to soft-food diet; limit intravenous infusions | Enteral nutrition: no | |
| Remove urine catheter on the morning of postoperative day 1; remove gastric tube within the first 12 h postoperatively; remove the abdominal drain after 48 h | Remove urine catheter on postoperative day 2–3; remove gastric tube after the first flatus; remove the abdominal drain 1–2 day before discharge |
Characteristics of patients with portal hypertension
| Factors | FT group | Non-FT group |
|
|---|---|---|---|
| Sex: | |||
| Male | 45 | 47 | 0.911 |
| Female | 23 | 25 | |
| Age | 44.2 ±12.4 | 45.5 ±11.1 | 0.514 |
| Etiology: | |||
| HBV | 45 | 47 | |
| HCV | 15 | 16 | |
| Autoimmune hepatitis | 7 | 8 | |
| Others | 1 | 1 | |
| BMI [kg/m2] | 23.8 ±5.9 | 23.3 ±5.2 | 0.595 |
| Longitudinal diameter of spleen [mm] | 171.6 ±34.4 | 163.4 ±32.2 | 0.205 |
| ICG R15 % | 21.2 ±13.4 | 20.5 ±14.6 | 0.768 |
| Child-Pugh | 7.03 ±1.26 | 7.04 ±1.34 | 0.956 |
| Class A | 26 | 28 | |
| Class B | 42 | 44 | |
| HVPG [mm Hg] | 18.2 ±7.2 | 17.2 ±6.7 | 0.396 |
| Variceal hemorrhage history: | 0.902 | ||
| Yes | 46 | 48 | |
| No | 22 | 24 | |
| White blood cells (WBC) [× 109/l] | 2.1 ±1.9 | 2.3 ±1.7 | 0.512 |
| Hemoglobin [g/dl] | 98.6 ±30.3 | 104.4 ±29.8 | 0.256 |
| Platelet count [× 109/ml] | 53.3 ±25.5 | 48.4 ±26.1 | 0.245 |
| D-dimer [μg/ml] | 1.3 ±0.5 | 1.2 ±0.4 | 0.192 |
| Total bilirubin [mmol/l] | 24.9 ±12.7 | 23.2 ±9.8 | 0.375 |
| Prothrombin time [s] | 15.8 ±2.4 | 16.2 ±2.2 | 0.305 |
| Prothrombin activity (PTA, %) | 65.2 ±10.4 | 67.3 ±11.6 | 0.262 |
BMI – body mass index, ICG R15 – Indocyanine green 15-minute retention rate, HVPG – hepatic venous pressure gradient. All of the values represent the mean ± SD (standard deviation).
Intra- and post-operative data
| Parameter | FT group | Non-FT group |
|
|---|---|---|---|
| Operation time [min] | 242.4 ±67.3 | 238.5 ±78.4 | 0.753 |
| Blood loss [ml] | 283.8 ±134.2 | 296.2 ±118.4 | 0.563 |
| Abdominal drain [days] | 3.2 ±1.6 | 5.4 ±2.1 | < 0.001 |
| First flatus [days] | 2.4 ±1.4 | 3.1 ±1.6 | 0.007 |
| First defecation [days] | 3.9 ±1.4 | 5.1 ±2.1 | < 0.001 |
| Taking liquid food [days] | 4.5 ±1.8 | 6.2 ±2.3 | < 0.001 |
| Postoperative hospital stay [days] | 6.3 ±2.3 | 8.4 ±2.2 | 0.001 |
Postoperative complications and follow-up data
| Parameter | FT group | Non-FT group |
|
|---|---|---|---|
| Emergency operation for bleeding, | 2 | 2 | 1 |
| Encephalopathy, | 0 | 0 | 1 |
| Mortality, | 1 | 1 | 1 |
| Incision site infection, | 1 | 2 | 0.441 |
| Pancreatic fistula, | 1 | 1 | 1 |
| Pneumonia, | 1 | 9 | 0.018 |
| Hemorrhage requiring transfusion, | 3 | 4 | 1 |
| Postoperative liver failure, | 0 | 0 | 1 |
| Severe ascites, | 2 | 10 | 0.032 |
| Urinary tract infection, | 1 | 8 | 0.034 |
| Intra-abdominal infection, | 1 | 1 | 1 |
| Follow-up data ( | 62 | 60 | |
| Recurrent esophagogastric bleeding, | 7 (11.3%) | 7 (11.7%) | 0.948 |
| Death | 0 | 0 | |
| Receive liver transplantation | 0 | 0 |
Figure 1A – Changes in the CRP and IL-6 levels preoperatively and postoperatively. B – Changes in D-dimer level and platelet count postoperatively
Pre – preoperatively, Post – postoperatively.
Portal vein thrombosis
| Parameter | FT group | Non-FT group | |
|---|---|---|---|
| Portal vein thrombosis: | |||
| Before operation | 10 (14.7%) | 12 (16.70%) | 0.75 |
| After operation | 7/58 (13.8%) | 17/60 (28.3%) | 0.028 |
| D-dimer [μg/ml]: | |||
| Post-1 | 4.1 ±1.5 | 4.4 ±1.9 | 0.344 |
| Post-3 | 7.8 ±1.8 | 10.4 ±2.3 | < 0.001 |
| Post-7 | 5.2 ±1.6 | 8.2 ±2.1 | < 0.001 |
| Post-14 | 4.3 ±2.3 | 6.2 ±2.5 | < 0.001 |
| Platelet count [× 109/l]: | |||
| Post-1 | 84.2 ±37.6 | 72.4 ±46.8 | 0.058 |
| Post-3 | 164.8 ±54.4 | 141.8 ±64.6 | 0.009 |
| Post-7 | 321.8 ±102.6 | 278.2 ±148.7 | 0.02 |
| Post-14 | 369.2 ±142.7 | 327.4 ±182.2 | 0.083 |